Neoadjuvant Anti-PD-1 Scores in Merkel Cell

]]>(MedPage Today) -- Almost half of patients with operable Merkel cell carcinoma (MCC) had pathologic complete responses (pCR) to neoadjuvant nivolumab (Opdivo), results of a small multicenter trial showed.Overall, 17 of 36 patients achieved pCR...